RE: MooremanI don't know. SLAM seems to be the perennial ugly duckling. Great announcements a few weeks ago then a brief flurry of activity then nothing. It seems if any other co. announced the sulphides that they did in a new zone then there would be all kinds of stock activity leading up to assay results. With SLAM it's been dead. In fact we've seen trading and the price drop off. I really don't get it. I'd be curious if mooreman does have any additional info. to add.